Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma

Summary Background Tiotropium is a long acting muscarinic antagonist (LAMA), licensed as triple therapy with inhaled corticosteroid and long‐acting beta‐agonist (ICS/LABA). There may be a synergistic benefit between LAMA and LABA as a consequence of receptor cross‐talk, which in turn could modify be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental allergy 2017-10, Vol.47 (10), p.1239-1245
Hauptverfasser: Jabbal, S., Manoharan, A., Lipworth, B. J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!